Evaluation of Prognostic response in HIV positive patients after Antiretroviral Therapy
Objective: The present study was aimed to monitor the prognostic response of antiretroviral therapy in HIV positive patients.
Methodology: The study was conducted on confirmed HIV positive patients registered at HIV treatment and care centre, PIMS. Islamabad from January 2013 to December 2015.. Among all HIV positive patients,276 adult cases were selected. There were 263 patients on first-line antiretroviral (ARV) therapy and 13 patients were shifted to 2nd line ARV therapy.CD4 cell counts and viral load (Polymerase chain reaction) monitoring was done after one year of starting ARV therapy.
Results: Out of 276 adult patients, 75%(n=207) were male and 25%(n=69) were females. Among 276 adult cases, 95.3% (n=263) patients were on first line ARV therapy. Patients on first line ARV therapy showed good prognostic response. There were 15.5%(n=40) patients having CD4+cells less than 350cells/µL. There were 84.5%(n=223) patients having CD4 +cells count greater than 350cells/µL There were 69%(n=182) patients having viral load <50copies/ml and 31%(n=81) patients who had viral load >50copies/ml.
Conclusion: First line ARV therapy given to HIV positive patients proved itself best both in respect of increasing the immunity of HIV positive patients by increasing the number of CD4 cells and also results in effective viral load suppression.
2. Moorhouse M, Conradie F, Venter F. What is the role of CD4 count in a large public health antiretroviral programme. AIDS.2016.45(2):224-227
3. Ford N, Stinson K, Davies M A. Is it safe to drop CD4 monitoring among virologically suppressed patients: A cohort evaluation from Khayelitsha, South Africa. AIDS. 2014. 28(16):131-135
4. Reynolds S, Sempa J, Kiragga A, et al. Is CD4 monitoring needed among Ugandan clients achieving virologic response to treatment? Abstract 56, 2014 Conference on Retroviruses and Opportunistic Infections; JAMA. 10(7): 03–06
5. O’Connor J, Smith C, Lampe F, Johnson M, Sabin C, Phillips A. Failure to achieve an adequate CD4 count response despite regular engagement in HIV care and consistent viral suppression. 19th Annual Conference of the British HIV Association(BHIVA);16–19April2013;Manchester,UK.http://www.bhiva.org/Annual Conference2013.aspx. Doi:10.1111/hiv.12119
6. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360(5):119–123
7. Mathis S, Khanlari B, Pulido F, Schechter M, Negredo E, Nelson M, et al. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. PLoS One 2011; 6(50):530-533
8. Olubajo B, Fearon KM, Ogunmoroti O. A Comparative Systematic Review of the Optimal CD4 Cell Count Threshold for HIV Treatment Initiation.IntPers on Infect Dis.2014.14:322-326 http://dx.doi.org/10.1155/2014/625670
9. Bussmann A N, Walter P, Hohler D, Eline N V.Clinical Prognostic Value of RNA Viral Load and CD4 Cell Counts during Untreated HIV-1 Infection—A Quantitative Review.AIDS.2013.4(5):456-467.
10. Sasisopan J, Maureen J.Initiation of ART in early asymptomatic HIV infection.New Eng journol of MED.2015.373(9):795-807
11. Oschieng W,Kitawi R C,Nzomo J T,Mwatelah R S.Correlates of adherence and treatment failure among Kenyan patients on long-term highly active antiretroviral therapy.J Acq imm def syn.2015.69(2):49-52.
12. Taieb F, Madec Y, Cournil A, Delaporte E.Virological success after 12 and 24 months of antiretroviral therapy in sub-saharan Africa.PLOS One 2017.12(4):939-945.
13. Lodi S, Phillips A, Logan R. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.Lancet HIV. 2015. 2(8): 335–343.
14. Teeraananchai S, Puthanakit T, Kerrsuchada .Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National Aids Programme.SJVErad.2019.5(1):33-35.
Copyright (c) 2020 Nadya Usman, Muhammad Abdul Rehman, Muhammad Bilal Ghafoor, Muhammad Ali Malik, Muhammad Shoaib Khan, Ajmal Shah Bukhari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All research articles published in the Journal of Rawalpindi Medical College (JRMC) are fully open access: immediately freely available to read, download, and share. Copyrights of all articles published in JRMC are retained by the authors. First publication rights are granted to JRMC. The journal/publisher is not responsible for subsequent uses of the work.
All articles are published under the Creative Commons Attribution (CC BY-SA 4.0) license.